PlainRecalls
FDA Drug Moderate Class II Terminated

PACLITAXEL 6MG/ML INJECTABLE 500 ML (1 PRODUCT)

Reported: August 22, 2012 Initiated: May 21, 2012 #D-1591-2012

Product Description

PACLITAXEL 6MG/ML INJECTABLE 500 ML (1 PRODUCT)

Reason for Recall

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Details

Units Affected
2 units
Distribution
Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies
Location
Ocala, FL

Frequently Asked Questions

What product was recalled?
PACLITAXEL 6MG/ML INJECTABLE 500 ML (1 PRODUCT). Recalled by Franck's Lab Inc., d.b.a. Franck's Compounding Lab. Units affected: 2 units.
Why was this product recalled?
Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 22, 2012. Severity: Moderate. Recall number: D-1591-2012.